Novelties in the field of antimicrobial compounds for the treatment of lower respiratory tract infections

By Cazzola M.   Sanduzzi A.   Matera M.G.  

Pulmonary Pharmacology & Therapeutics, Vol. 16, Iss. 3, 2003-06 ,pp. : 131-145

Elsevier

Access to resources Recommend Favorite

Azithromycin and lower respiratory tract infections

By Blasi F   Cazzola M   Tarsia P   Cosentini R   Aliberti S   Santus P   Allegra L  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 13, 2005-10 ,pp. : 2335-2351

Informa Healthcare

Access to resources Recommend Favorite

Clinical use of antimicrobial pharmacodynamic profiles to optimise treatment outcomes in community-acquired bacterial respiratory tract infections: application to telithromycin

By Nicolau David P  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 2, 2004-02 ,pp. : 229-235

Informa Healthcare

Access to resources Recommend Favorite

Respiratory tract infections: uncommon pathogens and misleading presentations

By Brill Simon E   Lim Wei Shen   Brown Jeremy S  

Clinical Medicine, Vol. 11, Iss. 6, 2011-12 ,pp. : 567-570

Royal College Of Physicians

Access to resources Recommend Favorite

Pharmacokinetics and Pharmacodynamics of Newer Oral Cephalosporins: Implications for Treatment of Community-Acquired Lower Respiratory Tract Infections

By Cazzola M.   Matera M.G.   Donner C.F.  

Clinical Drug Investigation, Vol. 16, Iss. 4, 1998-10 ,pp. : 335-346

Adis International

Access to resources Recommend Favorite